Delstrigo

Active Ingredient(s): Doravirine + Lamivudine + Tenofovir Disoproxil Fumarate
FDA Approved: * August 30, 2018
Pharm Company: * MSD MERCK CO
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Delstrigo Overview

Doravirine/lamivudine/tenofovir disoproxil fumarate (brand name Delstrigo) is a fixed-dose combination drug for the treatment of HIV/AIDS.[1] It contains doravirine (100 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg).[2] In the United States, it was approved by the Food and Drug Administration in August 2018 for the treatment of HIV-1 infection.[2] References ^ "Doravirine/lamivudine/tenofovir disoproxil fumarate - M...

Read more Delstrigo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Doravirine/lamivudine/tenofovir_disoproxil_fumarate

Recent Delstrigo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Doravirine + Lamivudine + Tenofovir Disoproxil Fumarate
  • Tablet: 100mg + 300mg + 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Delstrigo: (1 result)

Sorted by National Drug Code
  • 0006-5007 Delstrigo Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.

Drugs with one or more similar ingredients: (25 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 October 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 501 S. Cherry St, Suite 1100, Denver, CO, 80246, USA